PHARMA MAR, S.A. «...1617181920...» Page 18 out of 23 15/10/2020 08:29 PHARMA MAR, S.A. On business and financial situation PharmaMar signs an agreement with Jazz Pharmaceuticals to commercialize lurbinectedin in Canada Register number: 5026 29/09/2020 19:11 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes - Liquidity and counterparty agreements The company reports the transactions performed in the context of the Share Buy-back Program between 23 September and 25 September 2020. Ending of the Share Buy-back Program and resumption of the liquidity agreement. Register number: 4737 23/09/2020 17:37 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 16 September and 22 September 2020. Register number: 4597 17/09/2020 09:09 PHARMA MAR, S.A. On business and financial situation The Company has presented at the European Society of Medical Oncology (ESMO) Congress new results for lurbinectedin in sensitive patients with Small-Cell Lung Cancer, candidates for “re-challenge Register number: 4478 16/09/2020 17:42 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 9 September and 15 September 2020. Register number: 4468 09/09/2020 17:45 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 2 September and 8 September 2020. Register number: 4339 08/09/2020 07:59 PHARMA MAR, S.A. On business and financial situation The Company announces the creation of a new Virology Unit. Register number: 4263 02/09/2020 17:39 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 26 August and 1 September 2020. Register number: 4185 26/08/2020 17:50 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 19 August and 25 August 2020. Register number: 4130 19/08/2020 17:38 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 12 August and 18 August 2020. Register number: 4097 Page 18 out of 23 «...1617181920...»
